Background: Identifying new biomarkers is needed to overcome the diagnostic difficulties of pediatric multiple sclerosis (MS). Recently, we developed a new technique including CSF analysis of free light chain (FLC) monomers and dimers, which can improve diagnosis of adult MS. The present study has been designed to evaluate the utility of our technique for MS diagnosis in children. Methods: Patients with MS (n = 21) and non-MS demyelinating or inflammatory neurological disorders (n = 35) participated in the study. MS diagnosis was based on clinical and magnetic resonance imaging (MRI) findings. Western blot analysis was applied to examine FLC in the patients' CSF and serum. FLC indices for FLC monomer and dimer levels and κ/λ ratios were estimated. The samples were also analyzed by oligoclonality test. Results: The study revealed abnormally elevated levels of κ-FLC monomers and dimers in the CSF of 10 MS patients ("κ-type MS"). Increased amounts of λ dimers were found in six MS cases ("λ-type MS"), while high levels of both κ and λ FLC ("mixed type MS") were documented in three MS cases. MRI and clinical assessment showed a more aggressive disease form for the "mixed" and "λ-type" cases. Our method demonstrated higher sensitivity (90.5%) and specificity (91.4%) for discrimination between MS and
Introduction
Pediatric multiple sclerosis (MS) is considered a rare disease, accounting for only 3%-5% of all MS cases [1] . The first symptoms of MS often appear as individual demyelinative events, which can be clinically expressed as optic neuritis (ON), transverse myelitis (TMY) or show other neurological signs due to brainstem, cerebellar or hemispheric dysfunction. A growing body of evidence suggests that early treatment may slow the progression of MS [2] . Prediction and characterization of the future attacks might be helpful, but, unfortunately, such prognostic tests are still missing.
MS diagnosis is based on the combination of a typical demyelinative clinical presentation, which is not specific but suggestive for MS, plus a typical dynamic magnetic resonance imaging (MRI), which fits the McDonald criteria [3] . However, despite high sensitivity of MRI, other central nervous system (CNS) diseases may mimic MS radiologically [4] . In children the differential diagnosis is wider as compared to adults, even within the demyelinating spectrum disorder per se (e.g. acute disseminated encephalomyelitis [ADEM] vs. MS) [5] . In such cases a proper interpretation of the MRI findings might be difficult, and supporting laboratory data may be needed for correct diagnosis. In the commonly used diagnostic laboratory test, the demonstration of oligoclonal immunoglobulin (Ig) bands indicates an intrathecal production of Igs and supports the diagnosis of MS. Yet, the sensitivity of this method in pediatric MS is not clear, as it varies significantly in different studies [6] . Thus, a search for new biomarkers of pediatric MS, and developing of new, more precise diagnostic techniques is crucial for effective and timely treatment.
Intrathecal production of κ and λ Ig free light chains (FLC) is now regarded as an important immunological response developing in the CNS of MS patients. Thanks to the development of highly sensitive nephelometric FLC assays, the importance of FLC analysis in MS diagnosis was established. The nephelometric assay, allowing the quantification of total level of monomeric plus dimeric FLC, showed a significant increase of κ-FLC in the CSF of MS patients [7] [8] [9] . Yet, the specificity of this assay for the diagnosis of MS remained lower than that of the oligoclonality test [9] and even of the IgG index [8] .
Recently, we employed a semiquantitative Western blotting technique to analyze FLC in the CSF-serum sample pairs of adult patients with MS and related diseases [10] [11] [12] . In contrast to the previously used FLC assays [7] [8] [9] , we differentially analyzed the monomeric and covalently-bound dimeric forms of FLC. A number of the diagnostically useful FLC indices were established by us to distinguish MS from other neurological diseases in adults. The specificity and sensitivity of our method were both high compared to the oligoclonality test.
In the present study, aimed to reveal new reliable biomarkers of the pediatric MS, we applied our new methodological approach of FLC analysis and showed the utility of this technique in the MS diagnosis in children.
Materials and methods

Patients and samples
CSF and serum samples, collected from 64 pediatric patients (age range 1-17 years), were stored at −20 °C temperature until used. The patient groups were defined as follows: 1. Patients with definite MS diagnosis (n = 21); 2. Patients with other demyelinating neurological disorders (n = 20), including (ADEM, n = 3), neuromyelitis optica (NMO, n = 2), clinically isolated syndrome (CIS, n = 8), radiologically isolated syndrome (RIS, n = 2), transverse myelitis (TMY, n = 2), optic neuritis (ON) with the seropositivity to myelin oligodendrocyte glycoprotein (MOG+, n = 1), Guillain-Barré syndrome (GBS, n = 2); 3. Patients with non-demyelinating neurological diseases (n = 15).
These included cases with vasculitis (n = 1), Susac syndrome (n = 1), Rasmussen's encephalopathy (RE, n = 3, one of them electrical status epilepticus in sleep [ESES]), epilepsy (n = 2), Hashimoto disease (n = 1), migraine (n = 3), cerebral autosomaldominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL, n = 1), Sydenham's chorea (n = 1), monoplegia of left upper extremity (n = 1), non-MS (patient under observation, n = 1);
4. Control group (negative control) of patients (n = 8) with no evidence for demyelinating, inflammatory, autoimmune, or other well-defined neurological disease.
MS diagnosis was based on dissemination in time and space as demonstrated by clinical and MRI findings [3] . The study was approved by the institutional review board (Rabin Medical Center, 0104-15-RMC).
All participants have signed the written informed consent forms.
Oligoclonality test
A standard procedure for detection of IgG bands was used by employing high-resolution agarose gel electrophoresis (Hydragel six CSF) coupled with immunofixation (Sebia, Moulineaux, France) [10, 11] .
FLC analysis by Western blotting
CSF and serum samples were obtained from each patient participating in this study. Preparation of CSF and serum samples for Western blot analysis was performed as described in [11] [10] was used for quantitative evaluation of the intensity of FLC immunoreactive bands. The obtained intensity value in the tested CSF sample was normalized relative to that in the control sample: intensity of FLC band of positive control divided by intensity of FLC band of tested sample. The positive control sample, representing a mixture of CSF samples obtained from 15 patients with definite MS diagnosis, was included in each electrophoretic run alongside the tested samples. The following FLC indices (I) were calculated: 1. I 0 and I 1 -CSF λ and κ monomer level indices, respectively, 2. I 2 -CSF monomeric κ/λ ratio index, 3. I 3 -index to compare the κ/λ monomer ratio in the CSF vs. that in the serum (κ/λ SERUM /κ/λ CSF ), 4. I 4 -CSF λ dimer level index, 5. I 5 -CSF λ dimerization index: λ dimer/monomer ratio (λD/M), 6. I 6 -index to compare the λ dimerization in the CSF to that in the serum (λD/M SERUM /λD/M CSF ).
Of importance, I 0 , I 1 , I 2 , I 4 and I 5 indices are calculated using normalized intensity values, while I 3 and I 6 are calculated without normalization. (Notably, the lower index values point to the higher FLC levels, higher κ/λ ratios and higher λ dimerization values.)
Statistical analysis
Fisher's exact two-tailed test was applied to compare the three distinct MS patient subgroups (characterized by the differences in their FLC monomer-dimer patterns; see Results) with respect to the clinical and MRI data.
Results
FLC patterns in the MS patients
Analysis of the CSF-serum samples from control individuals and MS patients revealed striking differences between these two groups in relation to their FLC monomer-dimer (M-D) patterns in the CSF. The control individuals (n = 8) demonstrated a weak or no immunoreactivity in the area corresponding to FLC monomers (25 kDa) and dimers (50 kDa) in the CSF. In contrast, 19 out of 21 MS patients showed significantly increased levels of κ-FLC monomers and dimers, and/or increased levels of λ dimers ( Figure 1 ). To establish the clear-cut FLC criteria allowing the differentiation of MS from other non-MS neurological diseases, we determined quantitatively the intensities of immunoreactive FLC bands which were then used to calculate the FLC indices (I) as already described. The calculated FLC indices of pediatric patients with the clinically definite MS diagnosis are displayed in Table 1 . The 10 MS cases (patients #1-10) showed high intensity of immunoreactive κ-FLC bands (I 1 mean = 1.12 ± 0.96) together with the relatively low immunoreactivity of λ monomers (I 0 mean = 9.21 ± 8.71) and dimers (I 4 mean = 8.29 ± 7.87). Also, κ/λ ratio of monomeric FLC in the CSF was significantly higher than that in the serum of the same patient (I 3 mean = 0.19 ± 0.13) ("κ type" FLC pattern, Figure 1B ). In six MS cases (patients #11-16), the major abnormality was manifested by high intensity of dimeric λ-FLC bands (I 4 mean = 0.85 ± 0.67); in these cases the value of λ dimerization was much higher in the CSF than that in the serum (I 6 mean = 0.09 ± 0.007). Of note, the κ monomer levels varied widely (I 1 from 0.67 to 18) among these five patients ("λ type" FLC pattern, Figure 1C ). Three MS cases (patients #17-19) showed high levels of κ FLC (monomers and dimers) and λ dimers ("mixed type" FLC pattern, Figure 1D ). In all these MS cases the immunoreactivity of λ monomer bands was relatively weak (I 0 mean = 9.21 ± 8.71). 
FLC patterns in the non-MS patients
In patients with non-MS neurological diseases, the FLC patterns of 31 out of 34 cases were different from those observed in MS (Table 2 ). In two out of seven CIS cases the immunoreactivity of FLC monomer and dimer bands in the CSF was very weak as compared to MS (patients #24 and #26). In other two CIS patients (#23 and #25) the κ-FLCs were not detectable, while the λ-FLC bands were very weak ( Figure 2A , case 23, track 4). The CIS patient #27 showed only slight increase in FLC levels, which was incompatible with MS (I 1 = 10.5 and I 4 = 6.5).
In one of seven CIS cases (patient #22), κ monomer level was significantly increased (I 1 = 1.96), but in contrast to MS, no abnormalities were found by comparing the κ/λ monomer ratio in the CSF versus that in the serum (I 3 = 1.63). It is remarkable, that this patient showed seropositivity to myelin basic protein (MBP). The CIS patient #28 showed FLC pattern typical of MS; of note, this patient converted to MS during the 1st year of the patient follow-up. In ADEM, each of the three tested cases showed different FLC patterns, but none of the patterns resembled MS. The abnormally high levels of κ monomers were observed in two NMO cases: I 1 = 0.71 (patient #32) ( Figure 2B , track 4), and I 1 = 1.09 (patient #33). However, the other FLC indices in these NMO patients showed no abnormalities typical of MS (Table 2) . One patient with vasculitis (# 44, Susac syndrome) displayed the FLC pattern typical of MS. In the second vasculitis patient (#45), κ-FLCs were not measurable and only slight increase of λ dimer level was observed. Also, in one of the two RIS cases (patient #36) FLC pattern was close to normal, while the second RIS patient (#37) showed the MS-like FLC pattern (this patient had a family history of MS). Taken together, the FLC patterns in seven out of 35 non-MS cases were close to normal (i.e. similar to the negative control): CIS (n = 2), RE (n = 1), epilepsy (n = 1), monoplegia of left upper extremity (n = 1), migraine (n = 1), non-MS case under observation (n = 1). Mild/moderate abnormalities of FLC patterns were observed in other non-MS patients (n = 16), which included patients with CIS (n = 3), TMY (n = 2), GBS (n = 2), RIS (n = 1), migraine (n = 1), Sydenham's chorea (n = 1), Hashimoto disease (n = 1), ADEM (n = 1), ON & MOG+ (n = 1), RIS (n = 1) and CADASYL (n = 1). Nine out of 35 non-MS cases demonstrated highly abnormal FLC patterns which, however, 
FLC pattern analysis and oligoclonality test versus clinical diagnosis
The FLC diagnostic criteria were applied to support or disfavor the MS diagnosis (Tables 1 and 2 ). We found that in 19 out of 21 patients with clinically definite MS, the results of our FLC analysis supported this diagnosis (sensitivity 90.5%). The results of the oligoclonality test showed that 17 cases were oligopositive, three cases remained inconclusive, and one case was oligonegative (sensitivity 81%). Our FLC criteria were also applied for the non-MS patient group: 32 out of 35 non-MS cases tested disfavored the MS diagnosis (specificity 91.4%). The oligoclonality test rejected the MS diagnosis in 23 out of 35 cases, in four cases the results were inconclusive, and eight cases were oligopositive (specificity 65.7%).
FLC pattern analysis in MS versus MRI and clinical symptoms
Comparison of the FLC data with those of MRI and clinical assessment at the time of MS diagnosis (Table 3) showed that "mixed type" and "λ type" patients demonstrated a more active onset of the disease as compared to the "κ type" MS patients. Fisher's exact two-tailed test showed significant differences when comparing the MS patient group with "mixed plus λ types" versus that with "κ type" with respect to: 1. amount of brain lesions with a T2 number load >20, p = 0.015; 2. amount of active brain lesions with a number of gadolinium enhanced lesions (Gd+) > 3, p = 0.003; 3. presence of lesions in spinal cord, p = 0.009.
Discussion
The results of our present study have demonstrated the diagnostic importance of FLC monomers and dimers analysis in the diagnosis of pediatric MS. This method showed higher sensitivity (90.5%) and specificity (91.4%) in differentiation of MS from other neurological (non-MS) diseases as compared to the routine oligoclonal bands (OCB) test performed using Sebia agarose gel electrophoresis coupled with immunofixation (81% and 65.7%, respectively). In the future, however, we will check the diagnostic efficiency of our technique against the electrofocusing based OCB analysis which is presently considered as a preferred method to demonstrate oligoclonal Igs in CSF [13] .
It is worth mentioning that our Western blot based FLC monomer-dimer pattern analysis is semiquantitative and more laborious compared to the nephelometric FLC assay, which allows quantitative estimation of total FLC levels (monomers plus dimers). On the other hand, our method does not require expensive equipment and can be applied in an ordinary clinical laboratory providing valuable information on FLC pathology which cannot be obtained by nephelometry. We believe that these two techniques of FLC analysis may complement each other, thus further contributing to a precise diagnosis of MS. In addition, by using the nephelometric FLC assay, we can determine the FLC levels at which the electrophoretically resolved FLC bands are weak or unmeasurable and not indicative of MS (see Table 2 ). This is important from a practical point of view, as in such clear-cut non-MS cases our test may not be necessary.
Our FLC monomer-dimer analysis showed that similarly to our findings in the adult MS population [11] , the young MS patients displayed three distinct pathological FLC patterns, characterized by increased levels of κ monomers and dimers and/or λ dimers. The reasons for such differences in the immunological response of MS patients remain unclear. We suppose that these differences may be related to the heterogeneous nature of MS disease, indicating a possible link between FLC parameters and the clinical form of the disease, its severity and progression. Actually, the clinical and MRI data, obtained in this study, indicate the more aggressive onset of the disease in children with "mixed and λ-MS types" than those with "κ-MS type" (Table 3) . Longitudinal follow-up of MS patients is needed to understand whether the determination of FLC M-D pattern type could be helpful in predicting the disease course and prognosis and establishing the optimal treatment regiment at an individual patient level.
Comparison of the FLC patterns between CIS and MS patients was of special interest in our study, especially in view of the conflicting data obtained by using the nephelometric FLC assays [14] [15] [16] . According to some studies, the FLC levels were similar in these two diseases [14] . Other reports [15, 16] , however, showed that the FLC levels in CIS patients were significantly lower than those in MS. Our results were close to those of the latter studies: FLC levels in six out seven of our pediatric CIS patients were low compared to those of MS.
Another important issue is the prognostic value of FLC with respect to conversion of CIS to MS. One of our seven tested pediatric CIS patients showed FLC M-D pattern typical of MS; however, in his case the conversion to MS occurred within a 1-year period. In contrast, CIS patients with the FLC patterns disfavoring MS (six out of seven CIS cases) remained stable over 1-2.5-year period of their follow-up. In this respect it is worth mentioning the results of our 5-year follow-up of eight adult patients, who were diagnosed with CIS at the onset of disease, but showed MS-like FLC patterns. We found that seven of these eight CIS cases converted to MS, and only one of them remained stable (unpublished data). Interestingly, some studies employing nephelometric FLC assay [17, 18] showed that high κ FLC concentration in the CSF might predict the conversion of CIS to MS. In other studies, however, no significant differences in the κ FLC levels were found between the stable CIS patients and those who converted to MS [16] . We suppose that estimation of a single FLC parameter (e.g. κ-FLC only) is insufficient for the evaluation of the prognosis of demyelinating diseases, while the consideration of several FLC parameters (as done in our study) may be more fruitful for this purpose.
Taken together, high CSF levels of FLC per se are indicative of MS, but not sufficient for the precise diagnosis. Our study shows that the determination and combined use of different FLC parameters, including the assessment of FLC dimerization, may be of diagnostic and even of prognostic importance. Our preliminary results showed that the proportion of cases with "λ type" MS was high in our young MS patients (30%) compared to adults (10%) [11] . In fact, the increased λ dimer levels observed in our MS patients with "λ and mixed type" FLC patterns tend to associate with a more aggressive onset of the disease. The pathophysiologic relevance of the increased formation of the covalently-bound FLC dimers is not clear yet, but the structural differences of FLC monomers and dimers imply possible differences in their biological activity [19] . Structurally, FLC dimers resemble Fab region of whole Igs [20] , so the binding capabilities of dimers may prevail over that of monomers. The dimeric FLC may interact with B lymphocytes [21] and act as pathogenic miniautoantibodies by binding the factor H [22] . FLC are capable of sensitizing mast cells [23] [24] [25] , and a possibility was raised that dimerization of FLC is a necessary condition related to cross-linkage of membrane elements [26] . Although precise mechanisms of the enhanced formation of covalent FLC dimers are still not understood in MS, recent findings suggest that both the structural peculiarities of FLC, as well as the disease-related environmental conditions, such as oxidative stress, may play a role [27] [28] [29] . Further studies including the structural analysis of FLC and the determination of oxidative stress markers in MS may give insight to these issues and also contribute to the accurate diagnosis of the pediatric MS.
